Explain this page
Arphra AIPlain-English read on Tvardi Therapeutics, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $6.00 (+128.14%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.94% | -0.38% | -31.69% | -25.28% | -33.92% | -38.84% | -89.79% | -46.33% | -46.33% | -46.33% | -46.33% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$2.52
Bid
$2.48
10 sh
Ask
$2.68
10 sh
Spread
$0.200
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for TVRD.
Recent analyst activity
DB- Jun 08, 2026GradeBuyTvardi Therapeutics initiated with a Buy at H.C. WainwrightH.C. Wainwright
- Jun 08, 2026PT$9.00Tvardi Therapeutics initiated with a Buy at H.C. WainwrightH.C. Wainwright
Peers
No peer list available for TVRD.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|